Amino Acid Sequence Derived from Sars-Cov-2 and Use Thereof
AssigneesToagosei Co., Ltd., Kyoto University
InventorsTetsuhiko Yoshida, Nahoko Baileykobayashi, Yoshinori Yoshida
Life of this patent
Estimating the term…
Abstract
The herein disclosed art provides amino acid sequence information that can be used to produce antibodies to protein derived from the novel coronavirus (SARS-CoV-2). Synthetic peptide having the herein disclosed amino acid sequence information is recognized as an antigen in at least one species of mammal; contains any of the following amino acid sequences: (1) MKFLVFLGIITTVAA (SEQ ID NO: 1), (2) MFVFLVLLPLVSSQC (SEQ ID NO: 2), and (3) MKIILFLALITLATC (SEQ ID NO: 3); and has a total number of amino acid residues of not more than 20.
Claims5
A synthetic peptide that is recognized as an antigen in at least one species of mammal, wherein the synthetic peptide contains any of the following amino acid sequences:
- (SEQ ID NO:
- 1)
- (1) MKFLVFLGIITTVAA,
- (SEQ ID NO:
- 2)
- (2) MFVFLVLLPLVSSQC,
- and
- (SEQ ID NO:
- 3)
- (3) MKIILFLALITLATC.
- and has a total number of not more than 20 amino acid residues.
A composition comprising a moiety that is recognized as an antigen in at least one species of mammal, wherein the composition comprises a carrier protein and a synthetic peptide having a total number of not more than 20 amino acid residues, wherein the synthetic peptide contains any of the following amino sequences:
- (SEQ ID NO:
- 1)
- (1) MKFLVFLGIITTVAA,
- (SEQ ID NO:
- 2)
- (2) MFVFLVLLPLVSSQC,
- and
- (SEQ ID NO:
- 3)
- (3) MKIILFLALITLATC.
A method for producing an anti-SARS-CoV-2 antibody, wherein the antibody production method uses the amino acid information of any of the following amino acid sequences:
- (SEQ ID NO:
- 1)
- (1) MKFLVFLGIITTVAA,
- (SEQ ID NO:
- 2)
- (2) MFVFLVLLPLVSSQC,
- and
- (SEQ ID NO:
- 3)
- (3) MKIILFLALITLATC.
- as an antigen for producing the antibody.
Dependencies are inferred from the claim text.